UroGen Pharma
URGN
URGN
105 hedge funds and large institutions have $328M invested in UroGen Pharma in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 18 reducing their positions, and 12 closing their positions.
Holders
105
Holders Change
+4
Holders Change %
+3.96%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
16
Increased
50
Reduced
18
Closed
12
Calls
$344K
Puts
$336K
Net Calls
+$8K
Net Calls Change
-$525K
Top Buyers
1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$46.3M |
2 |
RI
2
RTW Investments
New York
|
$25.9M |
3 |
3
Morgan Stanley
New York
|
$13.7M |
4 |
4
BlackRock
New York
|
$25.8M |
5 |
SCM
5
Superstring Capital Management
New York
|
$3.83M |